Literature DB >> 8495344

Effects of acute and chronic cocaine on the activity of tuberoinfundibular dopamine neurons in the rat.

M H Baumann1, R B Rothman.   

Abstract

We investigated the effects of acute and chronic cocaine on dopamine (DA) synthesis in tuberoinfundibular dopamine (TIDA) neurons by measuring the accumulation of 3,4-dihydroxyphenylalanine (DOPA) in the median eminence (ME). Cocaine-induced prolactin (PRL) responses were evaluated for comparison. Acute cocaine inhibited DA synthesis in the ME and decreased circulating PRL. Chronic cocaine did not alter basal DOPA levels in TIDA nerve terminals or PRL levels in plasma. After repeated cocaine injections, cocaine's inhibitory effect on DA synthesis was abolished in the ME while the PRL response to drug was unchanged. These results suggest that TIDA neurons become tolerant to cocaine-induced suppression of DA synthesis after chronic cocaine exposure, but the altered sensitivity of TIDA neurons is not revealed by plasma PRL measures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495344     DOI: 10.1016/0006-8993(93)90792-l

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine.

Authors:  C Betancur; R Cabrera; E R de Kloet; D Pélaprat; W Rostène
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

2.  Transdermal selegiline and intravenous cocaine: safety and interactions.

Authors:  Elisabeth J Houtsmuller; Lisa D Notes; Thomas Newton; Nicolette van Sluis; Nora Chiang; Ahmed Elkashef; George E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2003-11-06       Impact factor: 4.530

3.  Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence.

Authors:  Ashwin A Patkar; Paolo Mannelli; Kenneth M Certa; Kathleen Peindl; Heather Murray; Michael J Vergare; Wade H Berrettini
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.